Symbole | YTM % | Volume | Prix % | Coupon % | Date d'échéance | Montant en suspens | Valeur nominale | Montant min de la dénomination | Émetteur |
---|---|---|---|---|---|---|---|---|---|
7,11% | 0 | 58,52% | 2,55% | 2050-11-13 | 1,5 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
6,54% | 0 | 67,47% | 2,35% | 2040-11-13 | 750 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
6,44% | 0 | 72,23% | 3,90% | 2062-03-15 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
BBMY4036425Celgene Corporation 5.25% 15-AUG-2043 | 6,40% | 65 K | 90,24% | 5,25% | 2043-08-15 | 4,06 M USD | 1 000,00 USD | 2 000,00 USD | Celgene Corp. |
BBMY4124214Celgene Corporation 4.625% 15-MAY-2044 | 6,38% | 20 K | 84,86% | 4,63% | 2044-05-15 | 3,69 M USD | 1 000,00 USD | 2 000,00 USD | Celgene Corp. |
6,37% | 0 | 73,46% | 3,70% | 2052-03-15 | 2 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
BBMY4275603Celgene Corporation 5.0% 15-AUG-2045 | 6,24% | 348 K | 88,78% | 5,00% | 2045-08-15 | 15,71 M USD | 1 000,00 USD | 2 000,00 USD | Celgene Corp. |
6,23% | 5,5 M | 75,06% | 3,25% | 2042-08-01 | 500 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
BBMY4597874Celgene Corporation 4.55% 20-FEB-2048 | 6,19% | 20 K | 84,30% | 4,55% | 2048-02-20 | 37,2 M USD | 1 000,00 USD | 2 000,00 USD | Celgene Corp. |
6,13% | 0 | 78,43% | 3,55% | 2042-03-15 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
6,10% | 975 K | 81,78% | 4,25% | 2049-10-26 | 3,75 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
BBMY4560589Celgene Corporation 4.35% 15-NOV-2047 | 6,09% | 10 K | 83,43% | 4,35% | 2047-11-15 | 13,57 M USD | 1 000,00 USD | 2 000,00 USD | Celgene Corp. |
6,07% | 598 K | 83,59% | 4,35% | 2047-11-15 | 1,24 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
BBMY3685700Celgene Corporation 5.7% 15-OCT-2040 | 5,98% | 290 K | 97,64% | 5,70% | 2040-10-15 | 2,3 M USD | 1 000,00 USD | 2 000,00 USD | Celgene Corp. |
5,93% | 0 | 87,23% | 4,50% | 2044-03-01 | 341,52 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
5,90% | 400 K | 86,82% | 4,55% | 2048-02-20 | 1,24 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
5,82% | 14 K | 89,11% | 4,63% | 2044-05-15 | 744,72 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
5,81% | 0 | 98,08% | 5,65% | 2064-02-22 | 1,75 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
5,79% | 5,02 M | 86,98% | 4,13% | 2039-06-15 | 2 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
5,70% | 0 | 108,43% | 6,40% | 2063-11-15 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
5,66% | 0 | 98,79% | 5,55% | 2054-02-22 | 2,75 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
5,61% | 110 K | 94,14% | 5,00% | 2045-08-15 | 741,72 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
5,60% | 0 | 107,12% | 6,25% | 2053-11-15 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
5,54% | 30 K | 119,38% | 6,88% | 2097-08-01 | 62,42 M USD | 1 000,00 USD | 1 000,00 USD | Bristol Myers Squibb Co. | |
5,50% | 60 K | 97,66% | 5,25% | 2043-08-15 | 218,37 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
5,48% | 0 | 100,17% | 5,50% | 2044-02-22 | 500 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
5,36% | 0 | 87,60% | 2,95% | 2032-03-15 | 1,75 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
5,33% | 50 K | 103,16% | 5,70% | 2040-10-15 | 151,01 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
5,24% | 531 K | 83,20% | 1,45% | 2030-11-13 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
5,21% | 0 | 104,84% | 5,88% | 2036-11-15 | 279,22 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
5,21% | 30 K | 107,18% | 6,13% | 2038-05-01 | 219,25 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
5,12% | 0 | 100,47% | 5,20% | 2034-02-22 | 2,5 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
BBMY4560450Celgene Corporation 3.45% 15-NOV-2027 | 5,12% | 980 K | 95,87% | 3,45% | 2027-11-15 | 16,55 M USD | 1 000,00 USD | 2 000,00 USD | Celgene Corp. |
5,05% | 0 | 105,18% | 5,90% | 2033-11-15 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
4,91% | 0 | 100,90% | 5,10% | 2031-02-22 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
4,88% | 1,26 M | 94,58% | 3,40% | 2029-07-26 | 2,37 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
4,84% | 0 | 104,23% | 5,75% | 2031-02-01 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
BBMY4597873Celgene Corporation 3.9% 20-FEB-2028 | 4,71% | 50 K | 97,86% | 3,90% | 2028-02-20 | 43,84 M USD | 1 000,00 USD | 2 000,00 USD | Celgene Corp. |
4,69% | 0 | 100,73% | 4,90% | 2029-02-22 | 1,75 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
4,67% | 0 | 97,34% | 3,25% | 2027-02-27 | 512,28 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
4,62% | 0 | 91,43% | 1,13% | 2027-11-13 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
4,62% | 1,24 M | 98,09% | 3,90% | 2028-02-20 | 1,45 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
4,60% | 1,59 M | 100,35% | 4,95% | 2026-02-20 | 500 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
4,54% | 0 | 100,41% | 4,95% | 2026-02-20 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
4,53% | 0 | 100,70% | 4,90% | 2027-02-22 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
4,52% | 67 K | 97,37% | 3,45% | 2027-11-15 | 517,67 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
4,48% | 400 K | 98,38% | 3,20% | 2026-06-15 | 1,74 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
4,37% | 83 K | 97,33% | 0,75% | 2025-11-13 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
4,12% | 1 M | 99,88% | 3,88% | 2025-08-15 | 228,73 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
4,03% | 100 K | 104,57% | 6,80% | 2026-11-15 | 255,95 M USD | 1 000,00 USD | 1 000,00 USD | Bristol Myers Squibb Co. | |
3,34% | 0 | 87,86% | 1,75% | 2035-05-15 | 575 M EUR | 1 000,00 EUR | 100 000,00 EUR | Bristol Myers Squibb Co. | |
2,93% | 0 | 99,49% | 1,00% | 2025-05-15 | 575 M EUR | 1 000,00 EUR | 100 000,00 EUR | Bristol Myers Squibb Co. | |
2,47% | 0 | 130,24% | 4,25% | 2049-10-26 | 500 K USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
2,39% | 0 | 122,76% | 4,13% | 2039-06-15 | 4,4 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
2,35% | 0 | 141,76% | 5,00% | 2045-08-15 | 1 K USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
2,32% | 0 | 137,60% | 4,55% | 2048-02-20 | 9,5 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
2,27% | 0 | 104,25% | 3,20% | 2026-06-15 | 5,95 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
1,47% | 0 | 116,80% | 3,90% | 2028-02-20 | 6,07 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
1,33% | 0 | 116,69% | 3,40% | 2029-07-26 | 26,56 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
1,28% | 0 | 114,77% | 3,45% | 2027-11-15 | 67 K USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |